Traditional Chinese medicine composition for treating hepatitis B and preparation method thereof

Abstract

The invention relates to a traditional Chinese medicine composition for treating hepatitis B. The traditional Chinese medicine composition is prepared from the following raw materials of radix rehmanniae, radix astragali seu hedysari, radix scutellariae, radix gentianae macrophyllae, fructus gardeniae, radix salviae miltiorrhizae, radix paeoniae alba, radix codcnopsitis pilosulas, rhizoma polygoni cuspidati, radix bupleuri, bighead atractylodes rhizome, poria cocos, fructus crataegi, semen lablab album, fructus jujubae, sclerotium of poria cocos, fructus schisandrae chinensis, scolopendra, radix isatidis, flos chrysanthemi indici, radix curcumae, herba elephantopi, fructus citrus sarcodactylis, sedum sarmentosum, herba artemisiae capillariae and radix aucklandiae. A preparation method comprises the following steps of cleaning the raw materials and components, crushing, adding water to decoct and extract, collecting an extracted solution, concentrating the extracted solution into an ointment, and cooling to room temperature, so as to obtain the traditional Chinese medicine composition. The traditional Chinese medicine composition for treating the hepatitis B has the advantages that the Chinese herbal medicines containing natural active ingredients are selected, and the formula and proportional ratio are scientific; any Western medicine hormone is not added, so that the safety effect is realized, any toxic or side effect is avoided; the obvious effects of clearing heat, diminishing inflammation, detoxifying, dredging liver, protecting liver and regulating immunity are realized. The preparation method has the advantages that the operation is simple and convenient, the cost is low, and the preparation method is very favorable for industrialized large-scale production.

Description

technical field [0001] The invention relates to the technical field of Chinese herbal medicines, in particular to a Chinese medicine composition for treating hepatitis B and a preparation method thereof. Background technique [0002] Hepatitis B virus is a global disease, according to the WHO report: global hepatitis B virus infection accounts for about 30% of the population, about 1.8 billion; chronic infection is about 35 million. The latter shows persistent viremia, and its virus level is more than 100-1000 times that of AIDS virus (HIV) and hepatitis C virus (HCV). Globally, carriers of hepatitis B virus in my country account for about 10% of the population, and there are about 30 million chronic hepatitis patients. Viral hepatitis B is mostly transmitted during the perinatal period, with onset in adolescence and exacerbation in young adults; therefore, most of the people it harms are young adults. Most patients recover through the natural course of the disease after i...

AI Technical Summary

Problems solved by technology

[0003] At present, there are many drugs for the treatment of acute and chronic hepatitis, such as interferons, nucleoside drugs such as acyclovir, lamivudine, adefovir dipivoxil, etc., as well as thymosin drugs, and hundreds of traditional Chinese medicines for liver protection. However, in the actual treatment and application, it is found that the curative effect of these drugs that have been used is not ideal, the effect is single, the side effects are more, the recurrence rate after treatment is high, and it is easy to rebound

Images